RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Evaluation of Doublet Chemotherapy Regimens for Advanced Cervical Cancer
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 4
SP 12
OP 13
DO 10.1177/155989770800800408
UL http://mdc.sagepub.com/content/8/4/12.2.abstract
AB The results of several Gynecologic Oncology Group (GOG) trials have established doublet chemotherapy with standard-dose cisplatin and paclitaxel as the preferred treatment for advanced or recurrent cervical cancer. The GOG 204 trial [NCT00064077] was conducted to evaluate 3 experimental cisplatin-containing doublet chemotherapy regimens against the standard of cisplatin and paclitaxel.